Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF and Autologous Cord Blood in Children with Cerebral Palsy
NCT02866331Phase 2Unknown
- Sponsor
- Hanyang University
- Start
- Jul 2016
- Primary completion
- Dec 2018
- Modality
- Cytokines & Interferons, Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim, autologous umbilical cord blood in cerebral palsy (CP), sponsored by Hanyang University. Status: unknown.
02
Drugs
filgrastimautologous umbilical cord blood
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT02866331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02866331.